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 Empirical Model-based Identification of Critical Quality Attributes 
in the Preclinical Design of Nanostructured Lipid Carriers. 
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In this study, an empirical modelling-based method is proposed and implemented to 
identify the critical quality attributes and speed up the formulation optimization of a 
nanostructured lipid carrier.  
 
Design of experiments. A mixture design with five factors, each associated with the 
nanoparticle formulation, was used: cationic lipid concentration (X1), fusogenic lipid 
concentration (X2), PEG surfactant concentration (X3), lecithin concentration (X4) and the 
hydrodynamic diameter (X5). The first four factors are dependant of each other and obey 
to a constraint equation about the nanoparticle composition. The nanoparticle properties 
considered were polydispersity (Y1), stability (Y2) and transfection efficacies on the Hela 
(Y3) and PC3 cell lines (Y4).  
 
Rational methodology of nanoparticle design. The empirical modelling methodology was 
split up into three consecutive steps. In the first part, we show that only the hydrodynamic 
diameter of the nanoparticle has a significant influence on the polydispersity response and 
we deduce its design space. In the second step, an empirical model of the nanoparticle 
stability is obtained, which allows us to identify two main contributors: the nanoparticle size 
and the concentration of surfactant PEG. A stability region in the (X3, X5) space is derived 
from this model. In the final part of this study, two response surface models are computed 
from the experimental data and are used to determine the optimal values of three 
formulation factors of the nanostructured lipid carrier. 
 
Results. Two different formulations have been synthetized and their in vitro properties 
have corroborated the predicted values provided by the previous models. This study 
confirms that a rational and rigorous engineering of nanoparticles is possible, owing to 
statistical design of experiments and empirical modelling techniques. Such approaches 
can drastically reduce the preclinical development duration of nanotechnologies in medical 
applications. 
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Fig.1 Empirical Model-based methodology to speed up the formulation optimization 
process of engineered nanoparticles. 
